Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Ovarian Neoplasms 1Carcinoma, Ovarian Epithelial 1

Interventions

Carboplatin 6Paclitaxel 4Therapeutics 2Taxes 2saracatinib 1rubitecan 1romidepsin 1epacadostat 1Toremifene 1Surveys and Questionnaires 1Radiotherapy 1Psychiatric Rehabilitation 1Polymerase Chain Reaction 1Pentetic Acid 1Palliative Care 1Ovariectomy 1N-(5-(2,3-dihydrobenzofuryl)sulfonyl)-N'-(3,4-dichlorophenyl)urea 1Minocycline 1Methods 1Metformin 1Hyperthermic Intraperitoneal Chemotherapy 1Heparin 1Gene Expression Profiling 1Gemcitabine 1Early Intervention, Educational 1Doxorubicin 1Depsipeptides 1Cisplatin 1Celecoxib 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Carcinoma, Ovarian Epithelial × Ovariectomy × Clear all
NCT00084370 2013-08-22

Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic Oophorectomy

University of Alabama at Birmingham

Phase NA Withdrawn
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡